These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2815265)

  • 1. Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients.
    Ubhi CS; Lam FT; Mavor AI; Giles GR
    Transplantation; 1989 Nov; 48(5):886-7. PubMed ID: 2815265
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy.
    Buturović J; Kandus A; Malovrh M; Bren A; Drinovec J
    Transplant Proc; 1990 Aug; 22(4):1726-7. PubMed ID: 2389443
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerulotubular function in long-term renal allograft recipients. A comparison of conventional therapy with cyclosporine.
    Propper DJ; Whiting PH; Mackay J; Catto GR
    Transplantation; 1990 Jul; 50(1):72-5. PubMed ID: 2368153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic complications in cyclosporin-treated kidney allograft recipients.
    Lancet; 1985 Sep; 2(8455):606-7. PubMed ID: 2863610
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ; Walker RG; d'Apice AJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract]   [Full Text] [Related]  

  • 8. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prazosin therapy in renal allograft recipients receiving cyclosporine.
    Kiberd BA
    Transplantation; 1990 Jun; 49(6):1200-1. PubMed ID: 2360263
    [No Abstract]   [Full Text] [Related]  

  • 11. Onset of dialysis encephalopathy in cyclosporine-treated renal allograft recipients.
    Hawley CM; Rigby RJ; Boyle RS; Petrie JJ
    Am J Kidney Dis; 1990 Apr; 15(4):364-8. PubMed ID: 2321647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of routinely available clinical data in differentiating renal allograft rejection from cyclosporine nephrotoxicity.
    Chan GL; Hodge EE; Chang HH
    Transplantation; 1989 Dec; 48(6):1075-7. PubMed ID: 2595772
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral blood T lymphocytes found in renal allograft recipients treated with cyclosporine.
    Liebert M; Rosenthal JT; Merrall E; Taylor RJ; Singh G; Starzl TE; Rabin BS; Hakala TR
    Transplantation; 1983 Aug; 36(2):200-2. PubMed ID: 6349044
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperuricemia after renal transplantation.
    Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
    Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
    O'Donoghue DJ; Johnson RW; Mallick NP; Gokal R; Ballardie FW; Bakran A; Pearson R; Scott P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
    [No Abstract]   [Full Text] [Related]  

  • 17. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients.
    Rocher LL; Landis C; Dafoe DC; Keyserling C; Swartz RD; Campbell DA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2093-5. PubMed ID: 3274476
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute myelogenous leukemia in a renal allograft recipient receiving cyclosporine therapy.
    Butler J; Korb S; Light J
    Transplantation; 1990 Apr; 49(4):813-5. PubMed ID: 2326877
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption profiles of renal allograft recipients receiving oral doses of cyclosporine: a pharmacokinetic study.
    Phillips TM; Karmi SA; Frantz SC; Henriques HF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):457-61. PubMed ID: 3284090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.